{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:20:53Z","timestamp":1790738453491,"version":"4.1.0"},"reference-count":187,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.vph.2018.04.006","type":"journal-article","created":{"date-parts":[[2018,4,22]],"date-time":"2018-04-22T22:09:28Z","timestamp":1524434968000},"page":"67-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Innate and adaptive immunity in atherosclerosis"],"prefix":"10.1016","volume":"107","author":[{"given":"Kapka","family":"Miteva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalinda","family":"Madonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1637-574X","authenticated-orcid":false,"given":"Raffaele","family":"De Caterina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Van Linthout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2018.04.006_bb0005","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1126\/science.180.4093.1332","article-title":"Atherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis","volume":"180","author":"Ross","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.vph.2018.04.006_bb0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis - an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2018.04.006_bb0015","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1161\/HYPERTENSIONAHA.108.118919","article-title":"Vascular-protective effects of high-density lipoprotein include the downregulation of the angiotensin II type 1 receptor","volume":"53","author":"Van Linthout","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2018.04.006_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2013.10.001","article-title":"LXR agonism improves TNF-alpha-induced endothelial dysfunction in the absence of its cholesterol-modulating effects","volume":"232","author":"Spillmann","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2018.04.006_bb0025","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/CIRCRESAHA.116.301313","article-title":"Inflammation and immunity in diseases of the arterial tree: players and layers","volume":"116","author":"Libby","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2018.04.006_bb0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.arr.2008.07.002","article-title":"Molecular inflammation: underpinnings of aging and age-related diseases","volume":"8","author":"Chung","year":"2009","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.vph.2018.04.006_bb0035","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1172\/JCI64098","article-title":"Cellular senescence and the senescent secretory phenotype: therapeutic opportunities","volume":"123","author":"Tchkonia","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.vph.2018.04.006_bb0040","doi-asserted-by":"crossref","DOI":"10.7603\/s40681-015-0001-1","article-title":"Emerging roles of frailty and inflammaging in risk assessment of age-related chronic diseases in older adults: the intersection between aging biology and personalized medicine","volume":"5","author":"Wu","year":"2015","journal-title":"Biomedicine (Taipei)."},{"key":"10.1016\/j.vph.2018.04.006_bb0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.arr.2015.01.003","article-title":"DAMPs as mediators of sterile inflammation in aging-related pathologies","volume":"24","author":"Feldman","year":"2015","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.vph.2018.04.006_bb0050","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1071059","article-title":"The danger model: a renewed sense of self","volume":"296","author":"Matzinger","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.vph.2018.04.006_bb0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.smim.2015.03.009","article-title":"PRR-signaling pathways: learning from microbial tactics","volume":"27","author":"Sellge","year":"2015","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.vph.2018.04.006_bb0060","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.coi.2013.12.004","article-title":"Molecular determinants of sterile inflammation","volume":"26","author":"Kono","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.vph.2018.04.006_bb0065","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11897-017-0337-9","article-title":"Inflammation - cause or consequence of heart failure or both?","volume":"14","author":"Van Linthout","year":"2017","journal-title":"Curr. Heart Fail Rep."},{"issue":"11","key":"10.1016\/j.vph.2018.04.006_bb0070","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004125","article-title":"Pathogenic role of the damage-associated molecular patterns S100A8 and S100A9 in Coxsackievirus B3-induced myocarditis","volume":"10","author":"M\u00fcller","year":"2017","journal-title":"Circ. Heart Fail."},{"issue":"9","key":"10.1016\/j.vph.2018.04.006_bb0075","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/nm1638","article-title":"Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock","volume":"13","author":"Vogl","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.vph.2018.04.006_bb0080","doi-asserted-by":"crossref","first-page":"e72138","DOI":"10.1371\/journal.pone.0072138","article-title":"S100A8 and S100A9 induce cytokine expression and regulate the NLRP3 inflammasome via ROS-dependent activation of NF-kappaB(1.)","volume":"8","author":"Simard","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vph.2018.04.006_bb0085","doi-asserted-by":"crossref","first-page":"41521","DOI":"10.1074\/jbc.M509442200","article-title":"S100A8 and S100A9 in human arterial wall. Implications for atherogenesis","volume":"280","author":"McCormick","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2018.04.006_bb0090","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/CIRCULATIONAHA.108.814582","article-title":"Myeloid-related protein-8\/14 is critical for the biological response to vascular injury","volume":"120","author":"Croce","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2018.04.006_bb0095","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1161\/CIRCULATIONAHA.105.607333","article-title":"Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events","volume":"113","author":"Healy","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2018.04.006_bb0100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ahj.2007.08.018","article-title":"Myeloid-related protein 8\/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial","volume":"155","author":"Morrow","year":"2008","journal-title":"Am. Heart J."},{"key":"10.1016\/j.vph.2018.04.006_bb0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.artres.2013.01.003","article-title":"The reality of aging viewed from the arterial wall","volume":"7","author":"Lakatta","year":"2013","journal-title":"Artery Res."},{"key":"10.1016\/j.vph.2018.04.006_bb0110","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/235709","article-title":"A low-dose combination of fluvastatin and valsartan: a new \"drug\" and a new approach for decreasing the arterial age","volume":"2015","author":"Janic","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.vph.2018.04.006_bb0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.arr.2008.12.002","article-title":"Signaling mechanisms of angiotensin II in regulating vascular senescence","volume":"8","author":"Min","year":"2009","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.vph.2018.04.006_bb0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11357-011-9207-7","article-title":"Mechanism of Ang II involvement in activation of NF-kappaB through phosphorylation of p65 during aging","volume":"34","author":"Kim","year":"2012","journal-title":"Age (Dordr.)"},{"key":"10.1016\/j.vph.2018.04.006_bb0125","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/HYPERTENSIONAHA.114.03618","article-title":"Matrix metalloproteinases promote arterial remodeling in aging, hypertension, and atherosclerosis","volume":"65","author":"Wang","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2018.04.006_bb0130","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.cjca.2016.02.070","article-title":"Vascular fibrosis in aging and hypertension: molecular mechanisms and clinical implications","volume":"32","author":"Harvey","year":"2016","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.vph.2018.04.006_bb0135","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/HYPERTENSIONAHA.112.191270","article-title":"Chronic matrix metalloproteinase inhibition retards age-associated arterial proinflammation and increase in blood pressure","volume":"60","author":"Wang","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2018.04.006_bb0140","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.yjmcc.2017.06.011","article-title":"Toll-like receptor-4 signaling pathway in aorta aging and diseases: \"its double nature\"","volume":"110","author":"Balistreri","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.vph.2018.04.006_bb0145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fimmu.2017.00043","article-title":"The NLRP3 and pyrin inflammasomes: implications in the pathophysiology of autoinflammatory diseases","volume":"8","author":"de Torre-Minguela","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vph.2018.04.006_bb0150","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/nyas.12458","article-title":"Mechanism of NLRP3 inflammasome activation","volume":"1319","author":"Sutterwala","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.vph.2018.04.006_bb0155","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.003870","article-title":"NOD2 (nucleotide-binding Oligomerization domain 2) is a major pathogenic mediator of Coxsackievirus B3-induced myocarditis","volume":"10","author":"Tschope","year":"2017","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.vph.2018.04.006_bb0160","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.vph.2018.04.006_bb0165","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1002\/eji.201444755","article-title":"Innate immune receptor NOD2 promotes vascular inflammation and formation of lipid-rich necrotic cores in hypercholesterolemic mice","volume":"44","author":"Johansson","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.vph.2018.04.006_bb0170","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.ijcard.2013.01.211","article-title":"Nalp3 inflammasome is activated and required for vascular smooth muscle cell calcification","volume":"168","author":"Wen","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.vph.2018.04.006_bb0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12950-016-0131-6","article-title":"Apolipoprotein A-I gene transfer exerts immunomodulatory effects and reduces vascular inflammation and fibrosis in ob\/ob mice","volume":"13","author":"Spillmann","year":"2016","journal-title":"J. Inflamm. (Lond)."},{"key":"10.1016\/j.vph.2018.04.006_bb0180","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.hlc.2013.01.012","article-title":"NLRP3 inflammasomes show high expression in aorta of patients with atherosclerosis","volume":"22","author":"Zheng","year":"2013","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.vph.2018.04.006_bb0185","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1172\/JCI114498","article-title":"Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6","volume":"85","author":"Loppnow","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2018.04.006_bb0190","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/eurheartj\/ehu203","article-title":"Anti-inflammatory therapies for cardiovascular disease","volume":"35","author":"Ridker","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2018.04.006_bb0195","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1172\/JCI112200","article-title":"Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines","volume":"76","author":"Bevilacqua","year":"1985","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2018.04.006_bb0200","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.ATV.0000064374.15232.C3","article-title":"Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice","volume":"23","author":"Kirii","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2018.04.006_bb0205","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0531-5565(99)00038-8","article-title":"Collagens and atherosclerosis","volume":"34","author":"Barnes","year":"1999","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.vph.2018.04.006_bb0210","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/apha.12466","article-title":"Vascular smooth muscle cell in atherosclerosis","volume":"214","author":"Chistiakov","year":"2015","journal-title":"Acta Physiol (Oxford)"},{"key":"10.1016\/j.vph.2018.04.006_bb0215","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1172\/JCI113346","article-title":"Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids","volume":"81","author":"Libby","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2018.04.006_bb0220","article-title":"Activation of Nlrp3 inflammasomes enhances macrophage lipid-deposition and migration: implication of a novel role of inflammasome in atherogenesis","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vph.2018.04.006_bb0225","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jss.2009.12.010","article-title":"Interleukin-lbeta induces migration of rat arterial smooth muscle cells through a mechanism involving increased matrix metalloproteinase-2 activity","volume":"169","author":"Wang","year":"2011","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.vph.2018.04.006_bb0230","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.jacc.2017.09.028","article-title":"Interleukin-1 Beta as a target for atherosclerosis therapy: biological basis of CANTOS and beyond","volume":"70","author":"Libby","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2018.04.006_bb0235","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1276","article-title":"Resolution of inflammation: the beginning programs the end","volume":"6","author":"Serhan","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.vph.2018.04.006_bb0240","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nri3399","article-title":"Neutrophil recruitment and function in health and inflammation","volume":"13","author":"Kolaczkowska","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.vph.2018.04.006_bb0245","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/ni.2109","article-title":"Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils","volume":"12","author":"Galli","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.vph.2018.04.006_bb0250","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1160\/TH11-07-0501","article-title":"Neutrophilic granulocytes - promiscuous accelerators of atherosclerosis","volume":"106","author":"Drechsler","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.vph.2018.04.006_bb0255","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1084\/jem.20122220","article-title":"Diverse novel functions of neutrophils in immunity, inflammation, and beyond","volume":"210","author":"Mocsai","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vph.2018.04.006_bb0260","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCRESAHA.111.257535","article-title":"Multiple roles for neutrophils in atherosclerosis","volume":"110","author":"Soehnlein","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2018.04.006_bb0265","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00011-013-0617-0","article-title":"Polymorphonuclear neutrophils and instability of the atherosclerotic plaque: a causative role?","volume":"62","author":"Della Bona","year":"2013","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.vph.2018.04.006_bb0270","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.5551\/jat.25940","article-title":"Usefulness of the neutrophil-to-lymphocyte ratio in predicting the severity of coronary artery disease: a Gensini score assessment","volume":"21","author":"Chen","year":"2014","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.vph.2018.04.006_bb0275","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/CIRCULATIONAHA.110.961714","article-title":"Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis","volume":"122","author":"Drechsler","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2018.04.006_bb0280","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2353\/ajpath.2010.090480","article-title":"Distinct infiltration of neutrophils in lesion shoulders in ApoE\u2212\/\u2212 mice","volume":"177","author":"Rotzius","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.vph.2018.04.006_bb0285","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/ATVBAHA.110.209296","article-title":"High neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of rupture-prone lesions","volume":"30","author":"Ionita","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2018.04.006_bb0290","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/eurheartj\/ehr123","article-title":"In vitro and in vivo evidence for the role of elastase shedding of CD163 in human atherothrombosis","volume":"33","author":"Moreno","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2018.04.006_bb0295","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/01.ATV.0000223901.08459.57","article-title":"Involvement of the antimicrobial peptide LL-37 in human atherosclerosis","volume":"26","author":"Edfeldt","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2018.04.006_bb0300","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/01.ATV.0000193567.88685.f4","article-title":"Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction","volume":"26","author":"Hemdahl","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2018.04.006_bb0305","doi-asserted-by":"crossref","first-page":"6399","DOI":"10.4049\/jimmunol.174.10.6399","article-title":"Neutrophil-derived heparin-binding protein (HBP\/CAP37) deposited on endothelium enhances monocyte arrest under flow conditions","volume":"174","author":"Soehnlein","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.vph.2018.04.006_bb0310","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1681\/ASN.V125932","article-title":"Proteinase 3 enhances endothelial monocyte chemoattractant protein-1 production and induces increased adhesion of neutrophils to endothelial cells by upregulating intercellular cell adhesion molecule-1","volume":"12","author":"Taekema-Roelvink","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9","key":"10.1016\/j.vph.2018.04.006_bb0315","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1161\/ATVBAHA.111.227116","article-title":"Human neutrophil peptides mediate endothelial-monocyte interaction, foam cell formation, and platelet activation","volume":"31","author":"Quinn","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2018.04.006_bb0320","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1182\/blood-2007-01-067918","article-title":"Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils","volume":"110","author":"Chalaris","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.vph.2018.04.006_bb0325","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.aaa8064","article-title":"Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis","volume":"349","author":"Warnatsch","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.vph.2018.04.006_bb0330","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/eurheartj\/ehv007","article-title":"Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction","volume":"36","author":"Stakos","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2018.04.006_bb0335","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00281-009-0141-z","article-title":"Myeloid cells in atherosclerosis: initiators and decision shapers","volume":"31","author":"Soehnlein","year":"2009","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.vph.2018.04.006_bb0340","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/CIRCULATIONAHA.108.806547","article-title":"Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis","volume":"120","author":"Norata","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2018.04.006_bb0345","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/ATVBAHA.112.300275","article-title":"Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice","volume":"33","author":"Lenglet","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.vph.2018.04.006_bb0350","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/CIRCRESAHA.109.200279","article-title":"A role of matrix metalloproteinase-8 in atherosclerosis","volume":"105","author":"Laxton","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2018.04.006_bb0355","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1161\/ATVBAHA.114.303326","article-title":"Matrix metalloproteinase-13 predominates over matrix metalloproteinase-8 as the functional interstitial collagenase in mouse atheromata","volume":"34","author":"Quillard","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2018.04.006_bb0360","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/720987","article-title":"Statin treatment is associated with reduction in serum levels of receptor activator of NF-kappaB ligand and neutrophil activation in patients with severe carotid stenosis","volume":"2014","author":"Lenglet","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.vph.2018.04.006_bb0365","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1161\/01.ATV.0000124923.95545.2c","article-title":"Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice","volume":"24","author":"Whitman","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2018.04.006_bb0370","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.vph.2018.04.006_bb0375","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.4049\/jimmunol.172.3.1455","article-title":"The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic","volume":"172","author":"Ferlazzo","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.vph.2018.04.006_bb0380","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.7326\/0003-4819-126-12-199706150-00028","article-title":"Lymphocyte subsets in severe atherosclerosis before revascularization","volume":"126","author":"Clerc","year":"1997","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.vph.2018.04.006_bb0385","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/01.ATV.6.2.131","article-title":"Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque","volume":"6","author":"Jonasson","year":"1986","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.vph.2018.04.006_bb0390","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00005072-199407000-00012","article-title":"Immunocytochemical studies of atherosclerotic lesions of cerebral berry aneurysms","volume":"53","author":"Kosierkiewicz","year":"1994","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.vph.2018.04.006_bb0395","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1002\/eji.1830241249","article-title":"Induction of natural killer cell migration by monocyte chemotactic protein-1, \u22122 and \u22123","volume":"24","author":"Allavena","year":"1994","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.vph.2018.04.006_bb0400","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/01.ATV.21.6.923","article-title":"Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- and activation-regulated chemokine, are expressed in human atherosclerotic lesions","volume":"21","author":"Greaves","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2018.04.006_bb0405","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.imlet.2015.09.006","article-title":"Natural killer cells in the innate immunity network of atherosclerosis","volume":"168","author":"Bonaccorsi","year":"2015","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.vph.2018.04.006_bb0410","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1161\/01.ATV.0000024082.46387.38","article-title":"Inflammation in atherosclerosis: lesion formation in LDL receptor-deficient mice with perforin and Lyst(beige) mutations","volume":"22","author":"Schiller","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2018.04.006_bb0415","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/cvr\/cvu016","article-title":"Natural killer (NK) cells augment atherosclerosis by cytotoxic-dependent mechanisms","volume":"102","author":"Selathurai","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2018.04.006_bb0420","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nri3671","article-title":"Monocytes and macrophages: developmental pathways and tissue homeostasis","volume":"14","author":"Ginhoux","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.vph.2018.04.006_bb0425","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.immuni.2013.08.007","article-title":"Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes","volume":"39","author":"Jakubzick","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.vph.2018.04.006_bb0430","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/sctm.16-0353","article-title":"Mesenchymal stromal cells modulate monocytes trafficking in Coxsackievirus B3-induced myocarditis","volume":"6","author":"Miteva","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.vph.2018.04.006_bb0435","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1182\/blood-2009-07-235028","article-title":"Comparison of gene expression profiles between human and mouse monocyte subsets","volume":"115","author":"Ingersoll","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.vph.2018.04.006_bb0440","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41467-017-00517-4","article-title":"Blood monocyte transcriptome and epigenome analyses reveal loci associated with human atherosclerosis","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.vph.2018.04.006_bb0445","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1172\/JCI28549","article-title":"Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques","volume":"117","author":"Tacke","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2018.04.006_bb0450","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1161\/CIRCULATIONAHA.107.745091","article-title":"Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice","volume":"117","author":"Combadiere","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2018.04.006_bb0455","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nature11260","article-title":"Myocardial infarction accelerates atherosclerosis","volume":"487","author":"Dutta","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.vph.2018.04.006_bb0460","doi-asserted-by":"crossref","first-page":"10340","DOI":"10.1073\/pnas.0604260103","article-title":"Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease","volume":"103","author":"Swirski","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vph.2018.04.006_bb0465","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/S0002-9440(10)61163-7","article-title":"Atherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine model","volume":"160","author":"Lessner","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.vph.2018.04.006_bb0470","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/CIRCRESAHA.113.302813","article-title":"Proliferating macrophages populate established atherosclerotic lesions","volume":"114","author":"Murphy","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2018.04.006_bb0475","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1172\/JCI75005","article-title":"Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression","volume":"127","author":"Rahman","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2018.04.006_bb0480","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1161\/CIRCRESAHA.117.310739","article-title":"Endothelial protective monocyte patrolling in large arteries intensified by western diet and atherosclerosis","volume":"120","author":"Quintar","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2018.04.006_bb0485","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/ni.2063","article-title":"The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes","volume":"12","author":"Hanna","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.vph.2018.04.006_bb0490","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1160\/TH16-02-0091","article-title":"Role and analysis of monocyte subsets in cardiovascular disease. Joint consensus document of the European Society of Cardiology (ESC) Working Groups \"Atherosclerosis & Vascular Biology\" and \"Thrombosis\"","volume":"116","author":"Weber","year":"2016","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.vph.2018.04.006_bb0495","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1182\/blood-2010-12-326355","article-title":"Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets","volume":"118","author":"Wong","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.vph.2018.04.006_bb0500","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1042\/CS20170009","article-title":"Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease","volume":"131","author":"Franca","year":"2017","journal-title":"Clin. Sci."},{"key":"10.1016\/j.vph.2018.04.006_bb0505","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/eurheartj\/ehq371","article-title":"CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease","volume":"32","author":"Rogacev","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2018.04.006_bb0510","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/eci.12023","article-title":"CD14++CD16+ monocytes in patients with acute ischaemic heart failure","volume":"43","author":"Wrigley","year":"2013","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.vph.2018.04.006_bb0515","doi-asserted-by":"crossref","first-page":"39483","DOI":"10.1038\/srep39483","article-title":"The \"Intermediate\" CD14(++)CD16(+) monocyte subset increases in severe peripheral artery disease in humans","volume":"6","author":"Wildgruber","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.vph.2018.04.006_bb0520","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00281-017-0656-7","article-title":"Monocyte and macrophage immunometabolism in atherosclerosis","volume":"40","author":"Groh","year":"2018","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.vph.2018.04.006_bb0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2013.09.019","article-title":"The role of monocytes in angiogenesis and atherosclerosis","volume":"63","author":"Jaipersad","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2018.04.006_bb0530","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1182\/blood-2005-04-1407","article-title":"Only a specific subset of human peripheral-blood monocytes has endothelial-like functional capacity","volume":"106","author":"Elsheikh","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.vph.2018.04.006_bb0535","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2249.2005.02934.x","article-title":"Macrophage activation switching: an asset for the resolution of inflammation","volume":"142","author":"Porcheray","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.vph.2018.04.006_bb0540","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ni0217-246b","article-title":"Corrigendum: the role of the local environment and epigenetics in shaping macrophage identity and their effect on tissue homeostasis","volume":"18","author":"Amit","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.vph.2018.04.006_bb0545","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.it.2017.03.001","article-title":"Macrophage immunometabolism: where are we (going)?","volume":"38","author":"Van den Bossche","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.vph.2018.04.006_bb0550","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1161\/ATVBAHA.117.309580","article-title":"Mitochondrial oxidative stress promotes atherosclerosis and neutrophil extracellular traps in aged mice","volume":"37","author":"Wang","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2018.04.006_bb0555","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1073\/pnas.0400983101","article-title":"Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria","volume":"101","author":"Verreck","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vph.2018.04.006_bb0560","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1189\/jlb.0602325","article-title":"The many faces of macrophage activation","volume":"73","author":"Mosser","year":"2003","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.vph.2018.04.006_bb0565","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","article-title":"The chemokine system in diverse forms of macrophage activation and polarization","volume":"25","author":"Mantovani","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.vph.2018.04.006_bb0570","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/09680519020080060501","article-title":"Modulating macrophage function with IgG immune complexes","volume":"8","author":"Anderson","year":"2002","journal-title":"J. Endotoxin Res."},{"key":"10.1016\/j.vph.2018.04.006_bb0575","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1160\/TH16-08-0593","article-title":"Pathophysiological relevance of macrophage subsets in atherogenesis","volume":"117","author":"Liberale","year":"2017","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.vph.2018.04.006_bb0580","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s10753-013-9621-3","article-title":"The adenosine-dependent angiogenic switch of macrophages to an M2-like phenotype is independent of interleukin-4 receptor alpha (IL-4Ralpha) signaling","volume":"36","author":"Ferrante","year":"2013","journal-title":"Inflammation"},{"key":"10.1016\/j.vph.2018.04.006_bb0585","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.1073\/pnas.1016086108","article-title":"HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells","volume":"108","author":"Feig","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vph.2018.04.006_bb0590","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1388-1981(00)00161-X","article-title":"Cholesterol and atherosclerosis","volume":"1529","author":"Libby","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.vph.2018.04.006_bb0595","doi-asserted-by":"crossref","DOI":"10.1186\/1476-511X-10-1","article-title":"Different responses to oxidized low-density lipoproteins in human polarized macrophages","volume":"10","author":"Hirose","year":"2011","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.vph.2018.04.006_bb0600","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.108.181040","article-title":"Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2","volume":"104","author":"Bae","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2018.04.006_bb0605","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/biof.5520240125","article-title":"Expression and synthesis of TGFbeta1 is induced in macrophages by 9-oxononanoyl cholesterol, a major cholesteryl ester oxidation product","volume":"24","author":"Sottero","year":"2005","journal-title":"Biofactors"},{"issue":"8","key":"10.1016\/j.vph.2018.04.006_bb0610","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/CIRCRESAHA.107.170779","article-title":"Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages","volume":"102","author":"Hughes","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2018.04.006_bb0615","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/CIRCRESAHA.109.215715","article-title":"Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2","volume":"107","author":"Kadl","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2018.04.006_bb0620","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.freeradbiomed.2011.08.026","article-title":"Oxidized phospholipid-induced inflammation is mediated by toll-like receptor 2","volume":"51","author":"Kadl","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.vph.2018.04.006_bb0625","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/CIRCRESAHA.111.247577","article-title":"Activating transcription factor 1 directs Mhem atheroprotective macrophages through coordinated iron handling and foam cell protection","volume":"110","author":"Boyle","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2018.04.006_bb0630","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/MOL.0b013e328356b145","article-title":"Heme and haemoglobin direct macrophage Mhem phenotype and counter foam cell formation in areas of intraplaque haemorrhage","volume":"23","author":"Boyle","year":"2012","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.vph.2018.04.006_bb0635","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2353\/ajpath.2009.080431","article-title":"Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype","volume":"174","author":"Boyle","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.vph.2018.04.006_bb0640","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3389\/fimmu.2014.00579","article-title":"Dynamic aspects of macrophage polarization during atherosclerosis progression and regression","volume":"5","author":"Peled","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vph.2018.04.006_bb0645","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1160\/TH08-07-0469","article-title":"Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes","volume":"101","author":"Newby","year":"2009","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.vph.2018.04.006_bb0650","article-title":"Classical macrophage activation up-regulates several matrix metalloproteinases through mitogen activated protein kinases and nuclear factor-kappaB","volume":"7","author":"Huang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vph.2018.04.006_bb0655","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","article-title":"Alternative activation of macrophages: mechanism and functions","volume":"32","author":"Gordon","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.vph.2018.04.006_bb0660","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.vph.2018.04.006_bb0665","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1161\/CIRCRESAHA.115.304992","article-title":"Loss of one copy of Zfp148 reduces lesional macrophage proliferation and atherosclerosis in mice by activating p53","volume":"115","author":"Sayin","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2018.04.006_bb0670","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1400223","article-title":"Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation","volume":"1","author":"Tang","year":"2015","journal-title":"Sci. Adv."},{"key":"10.1016\/j.vph.2018.04.006_bb0675","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.15252\/emmm.201404170","article-title":"Targeting macrophage histone deacetylase 3 stabilizes atherosclerotic lesions","volume":"6","author":"Hoeksema","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.vph.2018.04.006_bb0680","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1600224","article-title":"Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis","volume":"2","author":"Karunakaran","year":"2016","journal-title":"Sci. Adv."},{"key":"10.1016\/j.vph.2018.04.006_bb0685","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrcardio.2011.62","article-title":"Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets","volume":"8","author":"Lahoute","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.vph.2018.04.006_bb0690","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.vph.2018.04.006_bb0695","first-page":"359","article-title":"Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice","volume":"149","author":"Zhou","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.vph.2018.04.006_bb0700","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1161\/01.ATV.12.2.206","article-title":"T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1","volume":"12","author":"Stemme","year":"1992","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.vph.2018.04.006_bb0705","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/01.ATV.0000206122.61591.ff","article-title":"Adoptive transfer of CD4+ T cells reactive to modified low-density lipoprotein aggravates atherosclerosis","volume":"26","author":"Zhou","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2018.04.006_bb0710","unstructured":"van Wanrooij, E. J., de Jager, S. C., van Es, T., de Vos, P., Birch, H. L., Owen, D. A., Watson, R. J., Biessen, E. A., Chapman, G. A., van Berkel, T. J. & Kuiper, J. (2008) CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice, Arterioscler. Thromb. Vasc. Biol. 28, 251\u20137."},{"issue":"6","key":"10.1016\/j.vph.2018.04.006_bb0715","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1161\/ATVBAHA.108.165423","article-title":"A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice","volume":"28","author":"Braunersreuther","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2018.04.006_bb0720","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1172\/JCI6993","article-title":"Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells","volume":"104","author":"Mach","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2018.04.006_bb0725","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1161\/CIRCULATIONAHA.105.597526","article-title":"The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response","volume":"114","author":"van Loosdregt","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2018.04.006_bb0730","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0021-9150(99)00011-8","article-title":"Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines","volume":"145","author":"Frostegard","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2018.04.006_bb0735","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1073\/pnas.92.9.3893","article-title":"T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein","volume":"92","author":"Stemme","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vph.2018.04.006_bb0740","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI119465","article-title":"IFN-gamma potentiates atherosclerosis in ApoE knock-out mice","volume":"99","author":"Gupta","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2018.04.006_bb0745","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0002-9440(10)64820-1","article-title":"Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E\u2212\/\u2212 mice","volume":"157","author":"Whitman","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.vph.2018.04.006_bb0750","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1089\/10799900260100141","article-title":"IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E\u2212\/\u2212 mice","volume":"22","author":"Whitman","year":"2002","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.vph.2018.04.006_bb0755","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/01.ATV.0000059419.11002.6E","article-title":"Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse","volume":"23","author":"Buono","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2018.04.006_bb0760","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0002-9440(10)63471-2","article-title":"The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice","volume":"163","author":"Davenport","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.vph.2018.04.006_bb0765","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1161\/CIRCULATIONAHA.104.533463","article-title":"Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis","volume":"112","author":"Hauer","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2018.04.006_bb0770","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1161\/hh1901.098735","article-title":"Interleukin-18\/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability","volume":"89","author":"Mallat","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2018.04.006_bb0775","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1073\/pnas.0409015102","article-title":"T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses","volume":"102","author":"Buono","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vph.2018.04.006_bb0780","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/ATVBAHA.112.300871","article-title":"T-helper 2 immunity is associated with reduced risk of myocardial infarction and stroke","volume":"33","author":"Engelbertsen","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2018.04.006_bb0785","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.2353\/ajpath.2007.060857","article-title":"Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice","volume":"171","author":"King","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.vph.2018.04.006_bb0790","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.atherosclerosis.2014.12.046","article-title":"Plasma IL-5 concentration and subclinical carotid atherosclerosis","volume":"239","author":"Silveira","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2018.04.006_bb0795","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2174\/138945008783755520","article-title":"Natural antibodies in murine atherosclerosis","volume":"9","author":"Binder","year":"2008","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.vph.2018.04.006_bb0800","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/emmm.201201374","article-title":"Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype","volume":"4","author":"Cardilo-Reis","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.vph.2018.04.006_bb0805","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00395-016-0589-7","article-title":"Protective and pathogenic roles of CD8(+) T cells in atherosclerosis","volume":"111","author":"Cochain","year":"2016","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.vph.2018.04.006_bb0810","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.bbrc.2013.12.057","article-title":"CD8(+)CD25(+) T cells reduce atherosclerosis in apoE(\u2212\/\u2212) mice","volume":"443","author":"Zhou","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.vph.2018.04.006_bb0815","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/ATVBAHA.114.303567","article-title":"IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles","volume":"35","author":"Taleb","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2018.04.006_bb0820","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/nrcardio.2017.2","article-title":"Natural killer T cells in atherosclerosis","volume":"14","author":"Getz","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.vph.2018.04.006_bb0825","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/ATVBAHA.109.202671","article-title":"Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis","volume":"30","author":"Klingenberg","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2018.04.006_bb0830","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-2796.2010.02311.x","article-title":"Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine","volume":"269","author":"Wigren","year":"2011","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.vph.2018.04.006_bb0835","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/CIRCULATIONAHA.109.863431","article-title":"Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice","volume":"120","author":"Sasaki","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2018.04.006_bb0840","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1093\/eurheartj\/ehx517","article-title":"CD27 co-stimulation increases the abundance of regulatory T cells and reduces atherosclerosis in hyperlipidaemic mice","volume":"38","author":"Winkels","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2018.04.006_bb0845","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1172\/JCI83136","article-title":"Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis","volume":"126","author":"Cheng","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2018.04.006_bb0850","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/imr.12173","article-title":"Once a Treg, always a Treg?","volume":"259","author":"Sawant","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.vph.2018.04.006_bb0855","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1161\/CIRCRESAHA.116.309764","article-title":"Atherosclerosis-driven Treg plasticity results in formation of a dysfunctional subset of plastic IFNgamma+ Th1\/Tregs","volume":"119","author":"Butcher","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2018.04.006_bb0860","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1161\/CIRCRESAHA.116.308648","article-title":"CCR5+T-bet+FoxP3+ effector CD4 T cells drive atherosclerosis","volume":"118","author":"Li","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2018.04.006_bb0865","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1084\/jem.20100155","article-title":"B cell depletion reduces the development of atherosclerosis in mice","volume":"207","author":"Ait-Oufella","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vph.2018.04.006_bb0870","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1161\/ATVBAHA.115.306983","article-title":"Artery tertiary lymphoid organs control multilayered territorialized atherosclerosis B-cell responses in aged ApoE\u2212\/\u2212 mice","volume":"36","author":"Srikakulapu","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2018.04.006_bb0875","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1172\/JCI4533","article-title":"Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins","volume":"103","author":"Horkko","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2018.04.006_bb0880","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/CIRCRESAHA.111.248542","article-title":"B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions","volume":"109","author":"Kyaw","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2018.04.006_bb0885","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1161\/CIRCRESAHA.117.306044","article-title":"B-1b cells secrete atheroprotective IgM and attenuate atherosclerosis","volume":"117","author":"Rosenfeld","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2018.04.006_bb0890","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4049\/jimmunol.132.1.191","article-title":"Alterations in immunoglobulin synthesis by peripheral blood mononuclear cells from splenectomized patients with and without splenic regrowth","volume":"132","author":"Drew","year":"1984","journal-title":"J. Immunol."},{"key":"10.1016\/j.vph.2018.04.006_bb0895","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.4049\/jimmunol.1402869","article-title":"Low levels of IgM antibodies against an advanced glycation endproduct-modified Apolipoprotein B100 peptide predict cardiovascular events in nondiabetic subjects","volume":"195","author":"Engelbertsen","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.vph.2018.04.006_bb0900","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029371","article-title":"Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation","volume":"7","author":"Kyaw","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vph.2018.04.006_bb0905","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2018.04.006_bb0910","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2018.04.006_bb0915","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.atherosclerosis.2010.09.024","article-title":"Topical HDL administration reduces vein graft atherosclerosis in apo E deficient mice","volume":"214","author":"Feng","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2018.04.006_bb0920","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00109-011-0722-x","article-title":"Regression and stabilization of advanced murine atherosclerotic lesions: a comparison of LDL lowering and HDL raising gene transfer strategies","volume":"89","author":"Van Craeyveld","year":"2011","journal-title":"J. Mol. Med. (Berl)."},{"key":"10.1016\/j.vph.2018.04.006_bb0925","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.atherosclerosis.2010.01.001","article-title":"Impact of HDL on adipose tissue metabolism and adiponectin expression","volume":"210","author":"Van Linthout","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2018.04.006_bb0930","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1161\/CIRCULATIONAHA.107.710830","article-title":"Human apolipoprotein A-I gene transfer reduces the development of experimental diabetic cardiomyopathy","volume":"117","author":"Van Linthout","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2018.04.006_bb0935","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1161\/ATVBAHA.115.305887","article-title":"High-density lipoproteins reduce endothelial-to-mesenchymal transition","volume":"35","author":"Spillmann","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189117304640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189117304640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T07:08:40Z","timestamp":1693638520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189117304640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":187,"alternative-id":["S1537189117304640"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2018.04.006","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innate and adaptive immunity in atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2018.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}